Related Experiment Videos
Prognostic factors in axillary lymph node-negative (pN-) breast carcinomas
S Aaltomaa1, P Lipponen, M Eskelinen
1Department of Surgery, Kuopio University Hospital, Finland.
Summary
Mitotic indexes and nuclear factors accurately predict breast cancer recurrence and survival in node-negative patients. These factors, including mitotic activity index and nuclear perimetry, offer improved prognostic value over traditional histological grading.
Area of Science:
- Oncology
- Pathology
- Biostatistics
Background:
- Accurate prognostication is crucial for managing axillary lymph node-negative (pN-) breast carcinomas.
- Conventional histological grading has limitations in predicting patient outcomes.
- Novel histoquantitative factors require evaluation for their prognostic potential.
Purpose of the Study:
- To evaluate the prognostic value of mitotic indexes and nuclear factors in pN- breast carcinomas.
- To identify predictors of recurrence-free and disease-related survival.
- To compare the efficacy of these factors with conventional histological grading.
Main Methods:
- Histoquantitative analysis of 281 pN- breast carcinomas.
- Assessment of two mitotic indexes (mitotic activity index [MAI] and volume-corrected mitotic index [M/V]).
- Evaluation of nine nuclear factors, including nuclear perimetry and nuclear area standard deviation (S.D.), over a 12-year follow-up.
Main Results:
- M/V index, MAI, tumour size, and histological grade predicted recurrence-free survival.
- MAI, M/V index, tumour size, histological grade, and S.D. of nuclear perimetry predicted disease-related survival.
- MAI, adjuvant therapy, and tumour size were independent predictors of survival in Cox's analysis.
Conclusions:
- Mitotic indexes (MAI, M/V) and nuclear factors (nuclear perimetry, nuclear area S.D.) are significant predictors of survival and recurrence in pN- breast cancer.
- These factors may enhance or replace conventional histological grading for improved prognostication.
- The study supports the integration of these quantitative measures into routine breast cancer assessment.